Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Asset Utilization Ratio: 2011-2021

Historic Asset Utilization Ratio for Neurocrine Biosciences (NBIX) over the last 7 years, with Sep 2021 value amounting to 0.54.

  • Neurocrine Biosciences' Asset Utilization Ratio fell 22.06% to 0.54 in Q3 2021 from the same period last year, while for Sep 2021 it was 0.54, marking a year-over-year decrease of 22.06%. This contributed to the annual value of 0.69 for FY2020, which is 0.35% up from last year.
  • According to the latest figures from Q3 2021, Neurocrine Biosciences' Asset Utilization Ratio is 0.54, which was down 0.82% from 0.54 recorded in Q2 2021.
  • Neurocrine Biosciences' 5-year Asset Utilization Ratio high stood at 0.70 for Q2 2020, and its period low was 0.08 during Q2 2017.
  • In the last 3 years, Neurocrine Biosciences' Asset Utilization Ratio had a median value of 0.60 in 2019 and averaged 0.61.
  • Per our database at Business Quant, Neurocrine Biosciences' Asset Utilization Ratio surged by 389.02% in 2018 and then declined by 22.36% in 2021.
  • Neurocrine Biosciences' Asset Utilization Ratio (Quarterly) stood at 0.22 in 2017, then spiked by 110.82% to 0.47 in 2018, then surged by 35.38% to 0.63 in 2019, then grew by 1.91% to 0.65 in 2020, then fell by 22.06% to 0.54 in 2021.
  • Its last three reported values are 0.54 in Q3 2021, 0.54 for Q2 2021, and 0.58 during Q1 2021.